Weekly regimen of epirubicin and paclitaxel as second-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: Results of a phase II study

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Rozzi, Antonio ^a   Salerno, Margherita ^b   Bordin, Francesca ^c   De Marco, Ferdinando ^a   Nicola, Stefano Di ^a   Lanzetta, Gaetano ^a  

^a Istituto Neurotraumatologico Italiano (INI)   (Italy)

^b Palliative Care Center SAntonio da Padova   (Italy)

^c Sue Ryder Foundation   (Italy)

Author keywords

Epirubicin; Paclitaxel; Second line chemotherapy; Transitional cell carcinoma

Indexed keywords

CARBOPLATIN; EPIRUBICIN; GEMCITABINE; PACLITAXEL;

ADULT; AGED; ANEMIA; ARTICLE; CARDIOTOXICITY; CLINICAL ARTICLE; DRUG EFFICACY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYPERSENSITIVITY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; SENSORY NEUROPATHY; SURVIVAL TIME; THROMBOCYTOPENIA; TRANSITIONAL CELL CARCINOMA; TREATMENT RESPONSE;

EID: 84655164945     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9749-z     Document Type: Article

References (38)

1. Ferlay J, Bray F, Pisani P et al. Cancer incidence, mortality and prevalence worldwide. Lyon, France: IARC Press; 2001.
2. Sa Hussain ND James 2003 The systemic treatment of advanced and metastatic bladder cancer Lancet Oncol 4 489 497 (Pubitemid 37009957)
3. CN Sternberg A Yagoda HL Scher 1989 Methotrexate, vinblastine, doxorubicin and cisplatin for advanced transitional cell cancer of the urothelium. Efifcacy and patterns of response and relapse Cancer 64 2448 2458 (Pubitemid 20014925)
4. CJ Logothetis FH Dexeus L Finn 1990 A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors J Clin Oncol 8 1050 1055 (Pubitemid 20200193)
5. A Boutan-Laroze M Mahjoubi JP Droz 1991 M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. The French Federation of Cancer Centers experience Eur J Cancer 27 1690 1694
6. PJ Loehrer Sr LH Einhorn PJ Elson 1992 A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study J Clin Oncol 10 1066 1073
7. H Von der Maase SW Hansen JT Roberts 2000 Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study J Clin Oncol 18 3068 3077
8. MH Cohen M Rothmann 2001 Gemcitabine and cisplatin for advanced, metastatic bladder cancer J Clin Oncol 19 1229 1231 (Pubitemid 32176302)
9. H Von der Maase L Sengelov JT Roberts 2005 Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin with methotrexate, vinblastine, doxorubicin and cisplatin in patients with bladder cancer J Clin Oncol 23 4602 4608 (Pubitemid 46224062)
10. BJ Roth R dreicer LH Einhorn 1994 Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of Eastern cooperative oncology group J Clin Oncol 12 2264 2270 (Pubitemid 24346693)
11. D Papamichael CJ Gallagher RT Oliver 1997 Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter Br J Cancer 75 606 607 (Pubitemid 27085308)
12. DJ Vaughn CM Broome M Hussain 2002 Phase II trial of weekly paclitaxel in patients with previously treated advanced TCC J Clin Oncol 20 937 940 (Pubitemid 34141835)
13. F Joly N Houèdè S Noal 2009 Do patients with advanced urothelial carcinoma benefit from weekly paclitaxel chemotherapy? A CETUG phase II study Clin Genitourin Cancer 7 2 E28 E33
14. SM Tu E Hossan R Amato 1995 Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies J Urol 154 1719 1722
15. CJ Sweeney SD Williams DE Finch 1999 A phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium Cancer 86 514 518 (Pubitemid 29347415)
16. UN Vaishampayan JR Faulkner EJ Small 2005 Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest oncology group study Cancer 104 1627 1632 (Pubitemid 41437425)
17. T Kouno M Ando K Yonemori 2007 Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen Eur Urol 52 1115 1122 (Pubitemid 47332041)
18. JE Uhm HY Lim WS Kim 2007 Paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional-cell carcinoma of the urothelial tract Neoplasia 9 18 22
19. N Soga T Onishi K Arima 2007 Paclitaxel Carboplatin chemotherapy as a second-line chemotherapy for advanced platinum resistant urothelial cancer in Japanese cases Int J Urol 14 828 832 (Pubitemid 47313275)
20. T Suyama T Ueda S Fukasawa 2009 Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma Jpn J Clin Oncol 39 4 244 250
21. CN Sternberg F Calabrò G Pizzocaro 2001 Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy Cancer 92 2993 2998 (Pubitemid 33136193)
22. G Fechner R Siener M Reimann 2006 Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO trial AB 20/99) Int J Clin Pract 60 27 31 (Pubitemid 43732573)
23. N Shinohara T Harabayashi S Suzuki 2006 Salvage chemotherapy with paclitaxel, ifosfamide and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy Cancer Chemother Pharmacol 58 402 407 (Pubitemid 43800745)
24. U Kohler SS Olbricht G Fuechsel 1997 Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study Semin Oncol 24 5 suppl 17 S1740 S1743
25. SC Chen HK Chang YC Lin 2005 Increased feasibility of weekly epirubicin and paclitaxel as neoadjuvant chemotherapy for locally advanced breast carcinoma Onkologie 28 6-7 339 344
26. C Nisticò E Bria F Cuppone 2007 Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II study Anticancer Drugs 18 6 687 692 (Pubitemid 47343661)
27. J Garcia R Dreicer 2006 Systemic chemotherapy for advanced bladder cancer: update and controversies J Clin Oncol 24 2564 2569
28. Sridhar SS, Canil CM, Mukherjee SD et al. A phase II study of single-agent nab-paclitaxel as second-line therapy in patients with metastatic urothelial carcinoma. Proc ASCO 2010, abstr 279.
29. RS Witte P Elson B Bono 1997 Eastern cooperative oncology group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma J Clin Oncol 15 589 593 (Pubitemid 27074226)
30. JA Mc Caffrey S Hilton M Mazumdar 1997 Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma J Clin Oncol 15 1853 1857 (Pubitemid 27209514)
31. V Lorusso CF Pollera M Antimi 1998 A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Cooperative Group on Bladder Cancer Eur J Cancer 34 1208 1212 (Pubitemid 28342111)
32. CJ Sweeney BJ Roth FF Kabbinavar 2006 Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium J Clin Oncol 24 3451 3457 (Pubitemid 46638903)
33. S Culine C Theodore M De Santis 2006 A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen Br J Cancer 94 1395 1401 (Pubitemid 43772272)
34. R Dreicer S Li J Manola 2007 Phase II trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800): a trial of the Eastern Cooperative Oncology Group Cancer 110 759 763 (Pubitemid 47257651)
35. G Gomez-Abuin E Winquist WM Stadler 2007 A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia Invest New Drugs 25 181 185 (Pubitemid 46020878)
36. J Bellmunt C Theodore T Demkov 2009 Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract J Clin Oncol 27 4454 4461
37. G Sonpavde CN Sternberg JE Rosenberg 2010 Second-line systemic therapy and emerging drugs for metastatic transitional-cell carcinoma of the urothelium Lancet Oncol 11 9 861 870
38. Vaughn DJ, Hwang W, Munier C et al. Prognostic risk group classification for patients with platinum-refractory metastatic urothelial cancer treated with second-line chemotherapy. J Clin Oncol 2009; 27: 15s (suppl; abstr 5078).